Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. - Wikidata - awgldk - TriplyDB

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.

http://www.wikidata.org/entity/Q34277757

about

MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistance Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells.MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN.Histone deacetylase 1/Sp1/microRNA-200b signaling accounts for maintenance of cancer stem-like cells in human lung adenocarcinoma Epigenetic alteration and microRNA dysregulation in cancer MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met.Methylated DNA binding domain protein 2 (MBD2) coordinately silences gene expression through activation of the microRNA hsa-mir-496 promoter in breast cancer cell line MicroRNA gene polymorphisms and environmental factors increase patient susceptibility to hepatocellular carcinoma.Role of HGF/MET axis in resistance of lung cancer to contemporary management.The "Macro" World of microRNAs in Hepatocellular Carcinoma.Noncoding RNA as therapeutic targets for hepatocellular carcinoma.MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas.MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population.MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer.Function and clinical potential of microRNAs in hepatocellular carcinoma.Hsa-miR-449a genetic variant is associated with risk of gastric cancer in a Chinese population.miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3)Histone deacetylases and mechanisms of regulation of gene expression Transcriptional and translational regulation of C/EBPβ-HDAC1 protein complexes controls different levels of p53, SIRT1, and PGC1α proteins at the early and late stages of liver cancer.Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype.New insights on the role of epigenetic alterations in hepatocellular carcinoma.miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1.Regulation of microRNAs by epigenetics and their interplay involved in cancer.Increased miR-449a expression in colorectal carcinoma tissues is inversely correlated with serum carcinoembryonic antigen Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model.Non-coding RNAs as direct and indirect modulators of epigenetic regulation.hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma.GT198 (PSMC3IP) germline variants in early-onset breast cancer patients from hereditary breast and ovarian cancer families.Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs.MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.The role of vitamins and minerals in modulating the expression of microRNA.miRNA in hepatocellular carcinoma.Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma.The emerging role of hepatocyte growth factor in renal diseases.Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.

P2860

Q26765476-19FA43C6-B49A-4BDA-AC41-DC3AD1862C8B Q26799900-2ED2395D-EE68-4D75-B705-4B681C041B7E Q27005850-D2FD6751-BD96-445B-BEF4-6C70B6CA44E1 Q33917640-B16B305D-FF11-4AF5-B634-FBD8908ABCEB Q34233531-9D62A583-15E7-4B4E-9297-1D63B87C0EEB Q34287415-14A3E7CA-B359-42B8-8CC7-F18FB06C535D Q34392645-A176CD0A-930A-43C7-B31D-6DB8C2DB38A2 Q34755653-6E474DEE-6564-4185-879D-2C9C74B350E3 Q35034459-98CF4771-E15A-4D16-B012-E3A661E7AC42 Q35108392-7641A6F3-5817-49EA-B509-D3A27B7870BB Q35200337-CC88DFE0-9CF7-43E1-8110-EE8985D7404D Q35215896-007BD58E-1A3E-4E8B-B565-AB0204366732 Q35592207-BC13637A-FE2E-45CC-A97B-DBD4B9FA2CB3 Q35715931-47FFC213-5C3F-48C0-B73A-B5F5D83AD95C Q35752063-D97C7218-5D11-4278-A634-41F202216813 Q35809301-70E68FD3-B9AC-4839-8D63-F8E5F9A67CD3 Q36094073-5F617B16-199C-49FF-8673-DB6BB86742E0 Q36250644-B7613717-39CB-4863-BFBB-6BD12FBBCBAD Q36336198-A349D98D-3444-45D4-A551-5D1B541B53AC Q36375480-285A4B47-597B-4A10-8006-F1DEBC7FE245 Q36596220-F62AC581-CDAA-4FCC-905F-E4796C0D8B27 Q36734390-02B9DCCC-AFC1-43E2-9BF0-FB73F82B5E7F Q36850351-07011862-FB99-4F74-B693-1F0D91FAB6AB Q36860286-E1C125E9-11ED-435F-B2BC-54AE4EAFF879 Q37031728-63D44153-990E-4D2F-830D-3893E422F8A2 Q37046372-2E6DFF63-A9F8-4829-AF47-F86DDF134163 Q37418150-20F35C7C-C2AC-43BA-A172-09A27CCC7BAF Q37437986-9FB99849-427C-47AB-A2CE-9FA9D01C80DC Q37565083-5FC37974-F574-4A70-804E-F01A250FFDE3 Q37591537-014EC1DA-7236-459E-AB8F-47636F1EC663 Q37685458-81946EE3-C4F4-4091-A56C-82AC1751733C Q37725110-89468C4F-159B-42EA-A040-A3AA40F07C14 Q38153384-5A7654DF-1E1B-41DA-A913-67A4FA1EFB50 Q38209676-84A73B94-3B54-452D-BF60-38E71DB61B5F Q38210729-6A36288B-57E8-411A-A92E-6F9FE49FA013 Q38231531-81989D32-D676-4760-9E5D-5418AEAB2F8A Q38572855-29B45ADA-CA40-4B0C-96BA-5DC3E0262D8E Q38585471-F5BFB0DE-BCF5-4B13-AA3C-A3ACCACC2324 Q38605788-595A59F7-CF16-4644-BD2A-071E38CE1D96 Q38613525-A44BB2DC-250E-4489-8973-32A675FD516B

P2860

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.

http://www.wikidata.org/entity/Q34277757

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Histone deacetylases activate ...... epatocellular carcinoma cells.

@ast

Histone deacetylases activate ...... epatocellular carcinoma cells.

@en

Histone deacetylases activate ...... epatocellular carcinoma cells.

@nl

type

label

Histone deacetylases activate ...... epatocellular carcinoma cells.

@ast

Histone deacetylases activate ...... epatocellular carcinoma cells.

@en

Histone deacetylases activate ...... epatocellular carcinoma cells.

@nl

prefLabel

Histone deacetylases activate ...... epatocellular carcinoma cells.

@ast

Histone deacetylases activate ...... epatocellular carcinoma cells.

@en

Histone deacetylases activate ...... epatocellular carcinoma cells.

@nl

P1433

Q34277757-681390D4-3623-47A9-AA28-103AEF9152EA

P1476

Q34277757-5F6E3053-2BBC-4CB0-818B-438326F5E17D

P2093

Q34277757-6E02E892-1D9B-471E-BC71-8F32B3382AA7

Q34277757-93F0E1FE-4205-4312-8008-4AA9B88C861F

Q34277757-BE014530-07BC-4A48-9AA1-092FFF7CF4ED

Q34277757-CAA7E489-E9F6-4D04-9B9B-8B58C912C41A

Q34277757-D396D549-3FB0-4C60-BF1F-C16A020BB89D

Q34277757-E134D1B2-0906-4F8D-BB70-B57565521A0B

Q34277757-EE5E4498-BE07-44B8-88F4-3A3F11951AA9

Q34277757-F1B81FAE-CC70-484B-838A-978F8E5CECD5

Q34277757-FC36FA4D-224D-4359-BB95-E1A2D707DD25

P304

Q34277757-170BD327-73BF-4DB7-972D-B875FBEA7990

P31

Q34277757-F02D67EF-E5EB-4650-BDB9-E25FE6FFFD61

P356

Q34277757-7BE9E6C4-1C36-47E3-BEC7-D0AAAA154017

P407

Q34277757-A28542B3-8324-489A-B773-1991F6A71319

P433

Q34277757-82417CB7-8DA0-44B6-B3A1-E5F232DC5BDE

P478

Q34277757-A8BABC7A-41E7-4262-97CF-F606A857B5C2

P50

Q34277757-D4DECF2D-F030-44C8-AA0A-0B6648D957EE

P577

Q34277757-B4E92533-0A61-45CC-B02A-882D9B7FA80A

P698

Q34277757-BECA544D-6CC4-4AFD-BEB9-308514D8C910

P921

Q34277757-02F48CC1-D0C2-4854-9306-3AE5D1BA6571

P356

J.GASTRO.2012.05.033

P1433

Gastroenterology

P1476

Histone deacetylases activate ...... epatocellular carcinoma cells.

@en

P2093

Britta Skawran

http://www.w3.org/2001/XMLSchema#string

Engin Gürlevik

http://www.w3.org/2001/XMLSchema#string

Florian Kühnel

http://www.w3.org/2001/XMLSchema#string

Hans Kreipe

http://www.w3.org/2001/XMLSchema#string

Ludwig Wilkens

http://www.w3.org/2001/XMLSchema#string

Maria Sandbothe

http://www.w3.org/2001/XMLSchema#string

Marlies Eilers

http://www.w3.org/2001/XMLSchema#string

Reena Buurman

http://www.w3.org/2001/XMLSchema#string

Vera Schäffer

http://www.w3.org/2001/XMLSchema#string

P304

811-820.e15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2012.05.033

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Brigitte Schlegelberger

P577

2012-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22641068

http://www.w3.org/2001/XMLSchema#string

P921